Trial · NCT00648908
Results by group47
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 47
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Patients with Any TEAE | 264 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Patients with Any Serious AE | 94 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Patients with Any Possibly/Probably Related AE | 77 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Patients Withdrawn due to AE | 37 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Patients who Died | 4 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Maximum Severity /Patients with Any Mild TEAE | 16 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Maximum Severity /Patients with Any Moderate TEAE | 137 | Participants | |
| Summary of Treatment Emergent Adverse Events (TEAE). | Fampridine-SR 10mg (Twice a Day) | Maximum Severity /Patients with Any Severe TEAE | 111 | Participants | |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=265) >0-8 Weeks | 2.35 | Standard Deviation 0.96 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=242) >8-16 Weeks | 2.27 | Standard Deviation 0.95 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=249) >16-42 Weeks | 2.28 | Standard Deviation 1.02 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=222) >42-68 Weeks | 2.23 | Standard Deviation 1.10 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=204) >68-94 Weeks | 2.18 | Standard Deviation 1.05 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=190) >94-120 Weeks | 2.15 | Standard Deviation 1.00 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=177) >120-146 Weeks | 2.14 | Standard Deviation 1.03 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=156) >146-172 Weeks | 2.14 | Standard Deviation 0.99 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=143) >172-198 Weeks | 2.14 | Standard Deviation 1.06 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=137) >198-224 Weeks | 2.15 | Standard Deviation 1.05 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=58) >224-250 Weeks | 1.98 | Standard Deviation 1.09 | feet/second |
| Timed 25 Foot Walk (T25FW) | Fampridine-SR 10mg (Twice a Day) | (N=7) >250-276 Weeks | 1.56 | Standard Deviation 0.97 | feet/second |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00648908/results